EP3532098
Samsetning af and-CD19 mótefni með BCL-2 hindra og notkun á henni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.10.2017EP published:
7.4.2021EP application number:
17797564.6
EP translation filed:
18.5.2021Grant published:
15.6.2021EPO information:
European Patent Register
Max expiry date:
26.10.2037Expiry date:
26.10.2026Next due date:
31.10.2026
Title:
COMBINATION OF ANTI CD19 ANTIBODY WITH A BCL-2 INHIBITOR AND USES THEREOF
Timeline
Today
27.10.2017EP application
7.4.2021EP Publication
18.5.2021Translation submitted
15.6.2021Registration published
26.10.2026Expires
Owner
Name:
Incyte CorporationAddress:
1801 Augustine Cut-Off, Wilmington, Delaware 19803, US
Inventor
Name:
ENDELL, JanAddress:
80333 Munich, DE
Name:
PETROPOULOS, KonstantinAddress:
80997 Munich, DE
Name:
KELEMEN, PeterAddress:
81247 Munich, DE
Name:
BOXHAMMER, RainerAddress:
83059 Kolbermoor, DE
Name:
RÜCKERT, MarkusAddress:
82288 Kottgeisering, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16196184Date:
28.10.2016Country:
EP
Classification
Categories:
A61K 39/395, A61K 31/00, C07K 16/28, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 1.10.2021
Expires: 26.10.2022
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 3.10.2022
Expires: 26.10.2023
Payer: Patice ehf.
Number: 6
Paid: 3.10.2022
Expires: 26.10.2023
Payer: Patice ehf.
Number: 7
Paid: 19.10.2023
Expires: 26.10.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.10.2024
Expires: 26.10.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 22.10.2025
Expires: 26.10.2026
Payer: Árnason Faktor ehf.